Ultralife Statistics
Total Valuation
Ultralife has a market cap or net worth of $188.87 million. The enterprise value is $200.29 million.
| Market Cap | 188.87M |
| Enterprise Value | 200.29M |
Important Dates
The next estimated earnings date is Tuesday, May 28, 2024, before market open.
| Earnings Date | May 28, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Ultralife has 16.47 million shares outstanding. The number of shares has increased by 2.37% in one year.
| Shares Outstanding | 16.47M |
| Shares Change (YoY) | +2.37% |
| Shares Change (QoQ) | +0.83% |
| Owned by Insiders (%) | 1.82% |
| Owned by Institutions (%) | 70.66% |
| Float | 10.09M |
Valuation Ratios
The trailing PE ratio is 17.58 and the forward PE ratio is 18.69.
| PE Ratio | 17.58 |
| Forward PE | 18.69 |
| PS Ratio | 1.10 |
| Forward PS | 1.37 |
| PB Ratio | 1.44 |
| P/FCF Ratio | 235.69 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.41, with an EV/FCF ratio of 254.82.
| EV / Earnings | 19.20 |
| EV / Sales | 1.19 |
| EV / EBITDA | 10.41 |
| EV / EBIT | 13.06 |
| EV / FCF | 254.82 |
Financial Position
The company has a current ratio of 4.03, with a Debt / Equity ratio of 0.20.
| Current Ratio | 4.03 |
| Quick Ratio | 1.94 |
| Debt / Equity | 0.20 |
| Debt / EBITDA | 1.31 |
| Debt / FCF | 31.98 |
| Interest Coverage | 7.26 |
Financial Efficiency
Return on equity (ROE) is 8.40% and return on invested capital (ROIC) is 6.93%.
| Return on Equity (ROE) | 8.40% |
| Return on Assets (ROA) | 5.90% |
| Return on Capital (ROIC) | 6.93% |
| Revenue Per Employee | $314,655 |
| Profits Per Employee | $19,466 |
| Employee Count | 536 |
| Asset Turnover | 0.95 |
| Inventory Turnover | 2.75 |
Taxes
In the past 12 months, Ultralife has paid $2.79 million in taxes.
| Income Tax | 2.79M |
| Effective Tax Rate | 21.08% |
Stock Price Statistics
The stock price has increased by +162.24% in the last 52 weeks. The beta is 1.13, so Ultralife's price volatility has been higher than the market average.
| Beta (1Y) | 1.13 |
| 52-Week Price Change | +162.24% |
| 50-Day Moving Average | 10.07 |
| 200-Day Moving Average | 8.81 |
| Relative Strength Index (RSI) | 50.90 |
| Average Volume (30 Days) | 90,495 |
Short Selling Information
The latest short interest is 80,254, so 0.49% of the outstanding shares have been sold short.
| Short Interest | 80,254 |
| Short Previous Month | 65,420 |
| Short % of Shares Out | 0.49% |
| Short % of Float | 0.80% |
| Short Ratio (days to cover) | 0.77 |
Income Statement
In the last 12 months, Ultralife had revenue of $168.66 million and earned $10.43 million in profits. Earnings per share was $0.64.
| Revenue | 168.66M |
| Gross Profit | 43.23M |
| Operating Income | 13.51M |
| Pretax Income | 13.22M |
| Net Income | 10.43M |
| EBITDA | 19.24M |
| EBIT | 15.33M |
| Earnings Per Share (EPS) | $0.64 |
Balance Sheet
The company has $10.10 million in cash and $25.14 million in debt, giving a net cash position of -$15.04 million or -$0.91 per share.
| Cash & Cash Equivalents | 10.10M |
| Total Debt | 25.14M |
| Net Cash | -15.04M |
| Net Cash Per Share | -$0.91 |
| Equity / Book Value | 128.84M |
| Book Value Per Share | 7.82 |
| Working Capital | 70.93M |
Cash Flow
In the last 12 months, operating cash flow was $3.21 million and capital expenditures -$2.43 million, giving a free cash flow of $786,000.
| Operating Cash Flow | 3.21M |
| Capital Expenditures | -2.43M |
| Free Cash Flow | 786,000 |
| FCF Per Share | $0.05 |
Margins
Gross margin is 25.63%, with operating and profit margins of 8.01% and 6.19%.
| Gross Margin | 25.63% |
| Operating Margin | 8.01% |
| Pretax Margin | 7.84% |
| Profit Margin | 6.19% |
| EBITDA Margin | 11.41% |
| EBIT Margin | 9.09% |
| FCF Margin | 0.47% |
Dividends & Yields
Ultralife does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.37% |
| Shareholder Yield | -2.37% |
| Earnings Yield | 5.63% |
| FCF Yield | 0.42% |
Analyst Forecast
The average price target for Ultralife is $13.00, which is 13.44% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $13.00 |
| Price Target Difference | 13.44% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Ultralife has an Altman Z-Score of 3.55 and a Piotroski F-Score of 6.
| Altman Z-Score | 3.55 |
| Piotroski F-Score | 6 |